1. Moravan MJ, Fecci PE, Anders CK, et al. (2020) Current multidisciplinary management of brain metastases. Cancer, 126 (7): 1390-1406. [DOI:10.1002/cncr.32714]

2. Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer, 118(9): 2486-93. [DOI:10.1002/cncr.26515]

3. Milano MT, Grimm J, Niemirko A, et al. (2020) Single- and multifraction stereotactic radiosurgery dose/volume tolerances of the brain. Int J Radiat Oncol Biol Phys, 110(1): 68-86. [DOI:10.1016/j.ijrobp.2020.08.013]

4. Kocher M, Soffietti R, Abacioglu U, et al. (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol, 29(2): 134-41. [DOI:10.1200/JCO.2010.30.1655]

5. O'Beirn M, Benghiat H, Meade S, et al. (2018) The expanding role of radiosurgery for brain metastases. Medicines, 5(3): 90. [DOI:10.3390/medicines5030090]

6. Gaspar L, Scott C, Rotman M, et al. (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys, 37(4): 745-51. [DOI:10.1016/S0360-3016(96)00619-0]

7. Yamomoto M, Serizawa T, Sato Y, et al. (2013) Validity of two recently-proposed prognostic grading indices for lung, gastro-intestinal, breast and renal cell cancer patients with radiosurgically-treated brain metastases. J Neurooncol, 111(3): 327-35. [DOI:10.1007/s11060-012-1019-9]

8. Lorenzoni J, Devriendt D, Massager N, et al. (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys, 60(1): 218-24. [DOI:10.1016/j.ijrobp.2004.02.017]

9. Weltman E, Salvajoli JV, Brandt RA, et al. (2000) Radiosurgery for brain metastases: a score index for predicitng prognosis. Int J Radiat Oncol Biol Phys, 46(5): 1155-61. [DOI:10.1016/S0360-3016(99)00549-0]

10. Fessart E, Audouard RM, Le Tinier F, et al. (2020) Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series. Sci Rep, 10(1): 11201. [DOI:10.1038/s41598-020-68209-6]

11. Gutrie BL and Adler JR Jr. (1992) Computer-assisted preoperative plannning, interactive surgery, and frameless sterotaxy. Clin Neurosurg, 38: 112-131.

12. Schuler E, Lo A, Chuang CF, et al. (2020) Clinical impact of the VOLO optimizer on treatment plan quality and clinical treatment efficiency for CyberKnife. J Appl Clin Med Phys, 21(5): 38-47. [DOI:10.1002/acm2.12851]

13. Andrews DW, Scott CB, Sperduto PW, et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet, 363(9422): 1665-72. [DOI:10.1016/S0140-6736(04)16250-8]

14. Xuyao Y, Zhiyong Y, Yuwen W, et al. (2020) Improving stereotactic radiotherapy (SRT) planning process for brain metastases by Cyberknife system: reducing dose distribution in healthy tissues. J Cancer, 11(14): 4166-4172. [DOI:10.7150/jca.41102]

15. Zindler JD, Bruynzeel AME, Eekers DBP, et al. (2017) Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial. BMC Cancer, 17(1): 500. [DOI:10.1186/s12885-017-3494-z]

16. Shaw E, Scott C, Souhami L, et al. (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys, 47(2): 291-8. [DOI:10.1016/S0360-3016(99)00507-6]

17. Benedict SH, Yenice KM, Followill D, et al. (2010) Report no. 101- Stereotactic body radiation therapy: The report of AAPM Task Group 101, Medical Physics, 37: 4078-4101. [DOI:10.1118/1.3438081]

18. Dieterich S, Cavedon C, Chuang CF, et al. (2011) Report No. 135 - report of AAPM TG 135: Quality assurance for robotic radiosurgery. Medical Physics, 38, 2914-2936. [DOI:10.1118/1.3579139]

19. Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer, 45: 228-247. [DOI:10.1016/j.ejca.2008.10.026]

20. Mahajan A, Ahmed S, McAleer MF, et al. (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single centre, randomised, controlled, phase 3 trial. Lancet Oncol, 18(8): 1040-1048. [DOI:10.1016/S1470-2045(17)30414-X]

21. Brown PD, Jaeckle K, Ballman KV, et al. (2016) Effect of radiosurgery alone vs radiosurgery with whole-brain radiation therapy on cognitive function in patients with 1 to 3 metastases: A randomized clinical trial. JAMA, 316(4): 401-409. [DOI:10.1001/jama.2016.9839]

22. El Shafie RA, Dresel T, Weber D, et al. (2020) Stereotactic cavity irradiation or whole-brain radiotherapy following brain metastases resection-outcome, prognostic factors, and recurrence patterns. Front Oncol, 10: 693. [DOI:10.3389/fonc.2020.00693]

23. Atalar B, Choi CYH, Harsh 4th GR, et al. (2013) Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery, 72(2): 180-5. [DOI:10.1227/NEU.0b013e31827b99f3]

24. Lischalk JW, Oermann E, Collins SP, et al. (2015) Five-fraction stereotactic radiosurgery (SRS) for single inoperabl high-risk non-small cell lung cancer (NSCLC) brain metastases. Radiat Oncol, 10: 216. [DOI:10.1186/s13014-015-0525-2]

25. Lehrer EJ, Peterson JL, Zaorsky NG, et al. (2019) Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys, 103(3): 618-630. [DOI:10.1016/j.ijrobp.2018.10.038]

26. Wardak Z, Augustyn A, Zhu H, et al. (2016) Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery. J Neurooncol, 128(2): 251-7. [DOI:10.1007/s11060-016-2103-3]

27. Guschenritter T, Venur VA, Combs SE, et al. (2020) The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases. Cancers, 13(1): 70. [DOI:10.3390/cancers13010070]

28. El Shafie RA, Paul A, Bernhardt D, et al. (2018) Evaluation of stereotactic radiotherapy of the resection cavity after surgery of brain metastases compared to postoperative whole-brain radiotherapy (ESTRON)- a single- center prospective randomized trial. Neurosurgery, 83(1): 566-573. [DOI:10.1093/neuros/nyy021]

29. Minniti G, Scaringi C, Paolini S, et al. (2016) Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys, 95(4): 1142-8. [DOI:10.1016/j.ijrobp.2016.03.013]

30. Noel G, Simon JM, Valery CA, et al. (2003) Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol, 68(1): 15-21. [DOI:10.1016/S0167-8140(03)00207-X]

31. Marchan EM, Peterson J, Sio TT, et al. (2018) Postoperative cavity stereotactic radiosurgery for brain metastases. Front Oncol, 8: 342. [DOI:10.3389/fonc.2018.00342]

32. Lee SW, Jang S, Pyakuryal AP, et al. (2014) The impact of CyberKnife's prescription isodose percentage on intracranial target plannning. J Appl Clin Med Phys, 15(5): 5081. [DOI:10.1120/jacmp.v15i5.5081]

33. McGuinness CM, Gottschalk AR, Lessard E, et al. (2015) Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients. J App Clin Med Phys, 16(5): 284-295. [DOI:10.1120/jacmp.v16i5.5502]

34. Murai T, Ogino H, Manabe Y, et al. (2014) Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study. Clin Oncol (R Coll Radiol), 26(3): 151-8. [DOI:10.1016/j.clon.2013.11.027]

35. Millar WT, Hopewell JW, Paddick I, et al. (2015) The role of the consept of biologically effective dose (BED) in treatment planning in radiosurgery. Phys Med, 31(6): 627-33. [DOI:10.1016/j.ejmp.2015.04.008]

36. Wegner RE, Xu L, Horne Z, et al. (2020) Predictors of treatment interruption during frameless Gamma Knife Icon Stereotactic radiosurgery. Adv Radiat Oncol, 5(6): 1152-1157. [DOI:10.1016/j.adro.2020.06.025]

37. Wiggenraad R, Verbeek-de Kanter A, Kal HB, et al. (2011) Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol, 98(3): 292-7. [DOI:10.1016/j.radonc.2011.01.011]

38. Fokas E,Henzel M, Surber G, et al. (2012) Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. J Neurooncol, 109(1): 91-8. [DOI:10.1007/s11060-012-0868-6]

39. Zindler JD, Schiffelers J, Lambin P, Hoffmann AL (2018) Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study. Strahlenther Onkol, 194(6): 560-569. [DOI:10.1007/s00066-018-1262-x]

40. Cho YH, Lee JM, Lee D, et al. (2015) Experiences on two different stereotactic radiosurgery modalities of Gamma Knife and Cyberknife in treating brain metastases. Acta Neurochir (Wien), 157(11): 2003-9. [DOI:10.1007/s00701-015-2585-3]

41. Faruqi S, Ruschin M, Soliman H, et al. (2020) Adverse radiation effect after hypofractionated stereotactic radiosurgery in 5 daily fractions for surgical cavities and intact brain metastases. Int J Radiat Oncol Biol Phys, 106(4): 772-779. [DOI:10.1016/j.ijrobp.2019.12.002]

42. Jang SY, Lalonde R, Ozhasoglu C, et al. (2016) Dosimetric comparison between cone/Irıs-based and InCise MLC-based CyberKnife plans for single and multipl brain metastases. J Appl Clin Med Phys, 17(5): 184-199. [DOI:10.1120/jacmp.v17i5.6260]

43. Han EY, Wang H, Luo D, et al. (2019) Dosimetric comparison of fractionated radiosurgery plans using frameless Gamma Knife ICON and CyberKnife systems with linear accelerator-based radiosurgery plans for multiple large brain metastases. J Neurosurg, 132(5): 1473-1479. [DOI:10.3171/2019.1.JNS182769]